Patents by Inventor Kevin P. Horn

Kevin P. Horn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150093364
    Abstract: The invention is generally directed to treatment of neuronal injury. In particular, the invention is directed to reducing axonal retraction (“dieback”) that occurs as a result of the interaction of activated macrophages with dystrophic axons that are produced during nervous system acute or chronic injury. The invention is also directed to promoting axonal growth/regeneration. The invention is specifically directed to using stem cells or their secreted cellular factors, such as would be produced in conditioned cell culture medium, to ameliorate or prevent axonal dieback and/or promote growth/regeneration of axons.
    Type: Application
    Filed: December 5, 2014
    Publication date: April 2, 2015
    Applicants: ABT Holding Company, Case Western Reserve University
    Inventors: Sarah A. BUSCH, Kevin P. Horn, Robert W. Mays, Jerry Silver
  • Publication number: 20140186307
    Abstract: The invention is generally directed to treatment of neuronal injury. In particular, the invention is directed to reducing axonal retraction (“dieback”) that occurs as a result of the interaction of activated macrophages with dystrophic axons that are produced during nervous system acute or chronic injury. The invention is also directed to promoting axonal growth/regeneration. The invention is specifically directed to using stem cells or their secreted cellular factors, such as would be produced in conditioned cell culture medium, to ameliorate or prevent axonal dieback and/or promote growth/regeneration of axons.
    Type: Application
    Filed: October 3, 2013
    Publication date: July 3, 2014
    Applicants: Case Western Reserve University, ABT Holding Company
    Inventors: Sarah A. BUSCH, Kevin P. Horn, Robert W. Mays, Jerry Silver
  • Publication number: 20110293578
    Abstract: The invention is generally directed to treatment of neuronal injury. In particular, the invention is directed to reducing axonal retraction (“dieback”) that occurs as a result of the interaction of activated macrophages with dystrophic axons that are produced during nervous system acute or chronic injury. The invention is also directed to promoting axonal growth/regeneration. The invention is specifically directed to using stem cells or their secreted cellular factors, such as would be produced in conditioned cell culture medium, to ameliorate or prevent axonal dieback and/or promote growth/regeneration of axons.
    Type: Application
    Filed: September 4, 2009
    Publication date: December 1, 2011
    Applicants: Case Western Reserve University, ABT Holding Company
    Inventors: Sarah A. Busch, Kevin P. Horn, Robert W. Mays, Jerry Silver